Due to their administration via injection, women with PCOS treated with long-term GLP-1R agonists, including exenatide and liraglutide, also reported experiencing injection site reactions, particularly pruritus and erythema [85,86]. This evidence concerns the gene GLP1R and polycystic ovary syndrome.